Attached files
file | filename |
---|---|
EX-3.1 - EX-3.1 - SteadyMed Ltd. | a16-19724_1ex3d1.htm |
EX-10.1 - EX-10.1 - SteadyMed Ltd. | a16-19724_1ex10d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 5, 2016
SteadyMed Ltd.
(Exact name of registrant as specified in its charter)
Israel |
|
001-36889 |
|
Not applicable |
(State or other jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer |
5 Oppenheimer Street
Rehovot 7670105, Israel
(Address of principal executive offices, including zip code)
925-272-4999
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On August 8, 2016, the Board of Directors of SteadyMed Ltd. (the Company) approved the Eleventh Amended and Restated Articles of Association, subject to approval by the Companys shareholders at the Companys 2016 Annual Meeting of Shareholders on October 5, 2016 (the Annual Meeting). In the Eleventh Amended and Restated Articles of Association the requirement to maintain two external directors outside of the staggered director classes has been removed in light of recent changes under Israeli Companies Law, 5759-1999 and its regulations. The Companys stockholders approved the Eleventh Amended and Restated Articles of Association at the Annual Meeting and the Eleventh Amended and Restated Articles of Association became effective on that date.
A copy of the Eleventh Amended and Restated Articles of Association is attached hereto as Exhibit 3.1 and is incorporated herein by reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
The following is a summary of the proposals and the voting results from the Annual Meeting. A more complete description of each matter is described in more detail in the Companys definitive proxy statement filed with the Securities and Exchange Commission on August 31, 2016 (the Proxy Statement).
Proposal 1 Approval of the Companys Eleventh Amended and Restated Articles of Association. The Companys shareholders approved of the Eleventh Amended and Restated Articles of Association. The voting results are as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Vote |
|
15,146,310 |
|
34,508 |
|
100 |
|
1,890,775 |
|
Proposal 2 Reclassify Directors. The Companys shareholders reclassified Elizabeth Cermak and Donald Huffman (both former external directors) as Class I directors with terms expiring upon the annual general meeting of shareholders in 2018 and reclassified Ron Ginor (an existing Class I director) as a Class III director with a term expiring upon the Companys 2017 Annual General Meeting of Shareholders. The voting results are as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Vote |
|
14,785,872 |
|
393,546 |
|
1,500 |
|
1,890,775 |
|
Proposal 3 Election of Directors. The Companys shareholders elected Keith Bank and Stephen Farr to serve as Class II directors of the Company, each for a term of three years, to hold office until the Companys 2019 Annual General Meeting of Shareholders. The voting results are as follows:
Name |
|
For |
|
Against |
|
Abstain |
|
Broker Non-Vote |
|
Keith Bank |
|
12,576,340 |
|
37,708 |
|
2,566,870 |
|
1,890,775 |
|
Stephen Farr |
|
15,141,610 |
|
37,808 |
|
1,500 |
|
1,890,775 |
|
Proposal 4 Approval of the Adoption of an Amended Compensation Policy. The Companys shareholders approved the adoption by the Company of an amended compensation policy. The voting results are as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Vote |
|
14,500,389 |
|
675,879 |
|
0 |
|
1,895,425 |
|
Proposal 5 Appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Companys Independent Auditor for the year ending December 31, 2016. The Companys shareholders approved the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Companys independent auditor for the year ending December 31, 2016. The voting results are as follows:
For |
|
Against |
|
Abstain |
|
16,730,716 |
|
340,977 |
|
0 |
|
Proposal 6 Approval of an Amendment to the Companys Amended and Restated 2009 Stock Option Plan. The Companys shareholders approved an amendment to the Companys Amended and Restated 2009 Stock Option Plan. A copy of the Companys Amended and Restated 2009 Stock Option Plan is attached hereto as Exhibit 10.1. The voting results are as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Vote |
|
12,563,716 |
|
2,617,202 |
|
0 |
|
1,890,775 |
|
Proposal 7 Approval of the Grant of Stock Options to Mr. Jonathan Rigby, President and Chief Executive Officer of the Company. The Companys shareholders approved the grant of stock options to Mr. Jonathan Rigby, President and Chief Executive Officer of the Company. The voting results are as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Vote |
|
13,192,641 |
|
1,985,227 |
|
0 |
|
1,893,825 |
|
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. |
|
Description |
3.1 |
|
Eleventh Amended and Restated Articles of Association |
|
|
|
10.1 |
|
SteadyMed Ltd. Amended and Restated 2009 Stock Incentive Plan. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
STEADYMED LTD. |
|
|
|
|
|
|
|
By: |
|
|
|
/s/ David W. Nassif |
Date: October 11, 2016 |
|
David W. Nassif |